Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Coagulant Therapeutics presents preclinical data on CT-001

July 18, 2022

Novel hemophilia A murine model to test IdeS proteinase efficacy

July 18, 2022

CM-352 reduces MMP10-driven fibrinolysis in rivaroxaban-associated ICH

July 15, 2022

FVIII-QQ gene transfer therapy shows advantage for treating hemophilia A

July 14, 2022

Limitations of certain mouse models for sickle cell research highlighted

July 8, 2022

New coagulation factor XIa inhibitors discovered at Shanghai Leadingtac Pharmaceutical

July 7, 2022

KalVista Pharmaceuticals patents FXIIa inhibitors

June 29, 2022

Merck & Co. identifies new FXIa and/or KLKB1 inhibitors

June 16, 2022

EHA 2022 presentations describe sickle cell disease headway and headwinds

June 14, 2022

At EHA 2022, insights into multiple reasons for marrow failure

June 13, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...